正常老年人β-淀粉样蛋白水平与临床进展及纵向认知变化的关系
研究纳入534名认知正常老年人,基于Aβ PET的Centiloid分级分析5年进展风险。Aβ水平越高,进展为MCI或痴呆的风险及认知下降越显著;阴性者5年进展风险5%,阳性者25%,且随Centiloid升高而递增。
要点
- Aβ PET Centiloid分级可预测认知正常老年人向MCI或痴呆的进展风险。
- Aβ阴性者5年进展风险约5%,阳性者约25%,且随Centiloid水平升高而增加。
- 高和极高Aβ组认知综合评分显著下降,极高组达-0.35 SD/年。
核心结论
- 认知正常老年人5年内进展为MCI或痴呆的风险与Aβ PET水平相关,阴性者5%,阳性者25%,且从26-50 CL的12%递增至>100 CL的50%。
研究设计与样本
- 基于澳大利亚影像、生物标志物与生活方式研究的认知正常老年人,纳入具备Aβ PET且随访≥3年者共534例,年龄72±6岁,27% Aβ阳性,随访5.3±1.7年。
主要发现
- Aβ水平分布:阴性63%,不确定10%,中等10%,高14%,极高3%。
- 与Aβ阴性相比,中等Aβ进展风险比3.2(95%CI 1.3-7.6,p<0.05),高为7.0(95%CI 3.7-13.3,p<0.001),极高为11.4(95%CI 5.1-25.8,p<0.001)。
- 认知综合评分下降:中等组-0.02 SD/年(p=0.05),高组-0.08 SD/年(p<0.001),极高组-0.35 SD/年(p<0.001)。
关键数值与推荐
- Aβ水平按Centiloid量表分级:<15 CL阴性,15-25 CL不确定,26-50 CL中等,51-100 CL高,>100 CL极高;>25 CL近似阳性扫描。
- 5年进展风险:Aβ阴性5%,阳性25%,其中26-50 CL为12%,51-100 CL为28%,>100 CL为50%。
临床怎么用
- Aβ PET Centiloid分级可用于认知正常老年人的痴呆风险咨询。
- 该信息可能有助于临床前阿尔茨海默病试验的设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effect of β-amyloid (Aβ) level on progression risk to mild cognitive impairment (MCI) or dementia and longitudinal cognitive change in cognitively normal (CN) older individuals. METHODS: All CN from the Australian Imaging Biomarkers and Lifestyle study with Aβ PET and ≥3 years follow-up were included (n = 534; age 72 ± 6 years; 27% Aβ positive; follow-up 5.3 ± 1.7 years). Aβ level was divided using the standardized 0-100 Centiloid scale: <15 CL negative, 15-25 CL uncertain, 26-50 CL moderate, 51-100 CL high, >100 CL very high, noting >25 CL approximates a positive scan. Cox proportional hazards analysis and linear mixed effect models were used to assess risk of progression and cognitive decline. RESULTS: Aβ levels in 63% were negative, 10% uncertain, 10% moderate, 14% high, and 3% very high. Fifty-seven (11%) progressed to MCI or dementia. Compared to negative Aβ, the hazard ratio for progression for moderate Aβ was 3.2 (95% confidence interval [CI] 1.3-7.6; p < 0.05), for high was 7.0 (95% CI 3.7-13.3; p < 0.001), and for very high was 11.4 (95% CI 5.1-25.8; p < 0.001). Decline in cognitive composite score was minimal in the moderate group (-0.02 SD/year, p = 0.05), while the high and very high declined substantially (high -0.08 SD/year, p < 0.001; very high -0.35 SD/year, p < 0.001). CONCLUSION: The risk of MCI or dementia over 5 years in older CN is related to Aβ level on PET, 5% if negative vs 25% if positive but ranging from 12% if 26-50 CL to 28% if 51-100 CL and 50% if >100 CL. This information may be useful for dementia risk counseling and aid design of preclinical AD trials.
引用
- van der Kall LM, Truong T, Burnham SC, et al. Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals. Neurology. 2020. PMID: 33184233. doi:10.1212/WNL.0000000000011222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。